Skip to content

Study · Ex vivo tissue · hamster · 1989

1 result

Modulation of intrafollicular oestradiol in explanted hamster follicles does not affect oocyte meiotic status.

Racowsky C, Baldwin KV

Journal of reproduction and fertility1 Nov 1989Cited by 3 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabEx vivo tissueEfficacy outcome

    In explanted hamster follicles, enclomiphene did not significantly reduce the proportion of immature oocytes over the tested concentrations.

    In plain wordsIn lab tests with hamster follicles, enclomiphene did not significantly reduce the proportion of immature oocytes.

    Outcome
    No significant changeProportion of immature oocytes
    Study

    hamstern: not reported in source

    Explanted antral follicles
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    0-500 microM · intrafollicular injection · 6 or 10 hAs given in this study (hamster).

    Source sentences

    Summary
    The % GV was not significantly reduced by intrafollicular injection of either of the anti-oestrogens over the concentration ranges tested, or of the oestradiol-specific antiserum, which was injected in an amount adequate to bind all oestradiol accumulated during the incubation.
    2 context sentences
    Summary · context
    the anti-oestrogens, tamoxifen (0-200 microM) or enclomiphene citrate (0-500 microM)
    Summary · context
    Mature antral follicles were collected from PMSG-primed hamsters before the LH surge on Day 4 of the oestrous cycle and were incubated individually for 6 or 10 h under 95% O2 and 5% CO2.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.